✦ LIBER ✦

Dapagliflozin: A Once-Daily Oral Therapy Sodium-Glucose Cotransporter-2 Inhibitor for the Treatment of Adult Patients with Type 2 Diabetes

✍ Scribed by Idris, ; Khalid Jadoon,

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dapagliflozin: A Novel Sodium-Glucose Co

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Discovery of Dapagliflozin: A Potent, Se

✍ Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 203 KB

Development of the sodium-glucose co-tra

✍ Gerich, John E; Bastien, Arnaud 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 976 KB

Canagliflozin, an inhibitor of sodium–gl

✍ Lamos, Elizabeth M; Younk, Lisa M; Davis, Stephen N 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 473 KB

The Clinical Efficacy and Safety of Sodi

✍ Riser Taylor, Shawn; Harris, Kira B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Drug–Drug Interactions with Sodium-Gluco